Lancet (London, England)

• 

  Publication Venue For

  • Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial..  392:2705-2717. 2019
  • Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology..  393:1045-1055. 2019
  • Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial..  393:1021-1032. 2019
  • Heart failure drug treatment..  393:1034-1044. 2019
  • A Lancet Commission to address the global burden of hearing loss. 2019
  • Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials..  393:407-415. 2019
  • Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017..  392:1684-1735. 2018
  • Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017..  392:1736-1788. 2018
  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017..  392:1923-1994. 2018
  • Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017..  392:1789-1858. 2018
  • Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017..  392:2091-2138. 2018
  • Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017..  392:1995-2051. 2018
  • Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017..  392:1859-1922. 2018
  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial..  392:1519-1529. 2018
  • Alma-Ata at 40 years: reflections from the Lancet Commission on Investing in Health..  392:1434-1460. 2018
  • Lancet Commission on the Value of Death..  392:1291-1293. 2018
  • Age-related macular degeneration..  392:1147-1159. 2018
  • Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016..  392:1015-1035. 2018
  • Reimagining population health as convergence science..  392:367-368. 2018
  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)..  392:232-243. 2018
  • Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study..  391:2631-2640. 2018
  • Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial..  391:2346-2355. 2018
  • Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016..  391:2236-2271. 2018
  • Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial..  391:2116-2127. 2018
  • Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial..  391:1997-2007. 2018
  • The Tsinghua-Lancet Commission on Healthy Cities in China: unlocking the power of cities for a healthy China..  391:2140-2184. 2018
  • Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies..  391:1513-1523. 2018
  • NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial..  391:1174-1185. 2018
  • Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial..  391:850-859. 2018
  • Reducing health disparities: Bar Ilan Medical School's care transition service..  391:533-534. 2018
  • Rifampicin for Staphylococcus aureus bacteraemia: give it ARREST..  391:634-636. 2018
  • Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial..  391:741-747. 2018
  • Respiratory and cardiovascular responses to walking down a traffic-polluted road compared with walking in a traffic-free area in participants aged 60 years and older with chronic lung or heart disease and age-matched healthy controls: a randomised, crossover study..  391:339-349. 2018
  • Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial..  391:205-218. 2018
  • Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial..  391:219-229. 2018
  • Secondary prevention shifts into second gear..  391:181-182. 2018
  • Global hearing health care: new findings and perspectives..  390:2503-2515. 2017
  • Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).  390:2549-2558. 2017
  • Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults..  390:2627-2642. 2017
  • Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial..  390:2160-2170. 2017
  • Department of Error..  390:e38. 2017
  • A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial..  390:1737-1746. 2017
  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial..  390:1833-1842. 2017
  • Innovating through "interesting times" in global health..  390:e33-e34. 2017
  • Department of Error..  390:e23. 2017
  • Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016..  390:1423-1459. 2017
  • Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016..  390:1260-1344. 2017
  • Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016..  390:1211-1259. 2017
  • Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016..  390:1084-1150. 2017
  • The oldest-old in China reply.  390:847-847. 2017
  • Cataracts..  390:600-612. 2017
  • The oldest-old in China - Authors' reply..  390:847. 2017
  • Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015..  390:231-266. 2017
  • Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial..  389:2214-2225. 2017
  • Proliferative diabetic retinopathy: laser or eye injection?.  389:2165-2166. 2017
  • Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial..  389:1799-1808. 2017
  • GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes..  389:1773-1775. 2017
  • STREAM characterisation correction..  389:2102. 2017
  • Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015..  389:1885-1906. 2017
  • Survival, disabilities in activities of daily living, and physical and cognitive functioning among the oldest-old in China: a cohort study..  389:1619-1629. 2017
  • ANTARCTIC: platelet function testing to adjust therapy.  389:1193-1193. 2017
  • Listerism then and now.  389:1002-1003. 2017
  • Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations..  389:951-963. 2017
  • Early goal-directed mobilisation after surgery - Authors' reply..  389:695-696. 2017
  • Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study..  389:805-814. 2017
  • Erratum: Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1775–1812)(S0140673616314702)(10.1016/S0140-6736(16)31470-2)).  389:e1. 2017
  • Erratum: Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1725–1774)(S0140673616315756)(10.1016/S0140-6736(16)31575-6)).  389:e1. 2017
  • Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants..  389:37-55. 2017
  • Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial..  388:2895-2903. 2016
  • Global health humanities: defining an emerging field..  388:2586-2587. 2016
  • Assessment of economic vulnerability to infectious disease crises..  388:2443-2448. 2016
  • Next generation maternal health: external shocks and health-system innovations..  388:2296-2306. 2016
  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015..  388:1659-1724. 2016
  • Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015..  388:1603-1658. 2016
  • Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015..  388:1545-1602. 2016
  • Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015..  388:1775-1812. 2016
  • Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015..  388:1459-1544. 2016
  • Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015..  388:1725-1774. 2016
  • Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015..  388:1813-1850. 2016
  • Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial..  388:1183-1192. 2016
  • Global surgery initiative in Greece: more than an essential initiative..  388:957. 2016
  • The economic burden of physical inactivity: a global analysis of major non-communicable diseases..  388:1311-1324. 2016
  • Rhythm control in atrial fibrillation..  388:829-840. 2016
  • IxCELL-DCM: rejuvenation for cardiac regenerative therapy?.  387:2362-2363. 2016
  • The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study..  387:2302-2311. 2016
  • Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials..  387:2026-2034. 2016
  • Protecting human security: proposals for the G7 Ise-Shima Summit in Japan..  387:2155-2162. 2016
  • Organ donation during the financial crisis in Greece..  387:1511-1512. 2016
  • REGULATE-PCI trial--Author's reply..  387:1510-1511. 2016
  • Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants..  387:1513-1530. 2016
  • The Institute of Medicine: ensuring integrity and independence in scientific advice on health..  387:1686-1692. 2016
  • Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants..  387:1377-1396. 2016
  • Erratum: On behalf of the REGULATE-PCI Investigators (Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): A randomised clinical trial. (The Lancet (2016) 387 (34956)).  387:1162. 2016
  • Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial..  387:1178-1186. 2016
  • Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial..  387:661-670. 2016
  • A medical-toxicological view of tattooing..  387:395-402. 2016
  • Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial..  387:349-356. 2016
  • Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial..  387:127-135. 2016
  • Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial..  387:136-145. 2016
  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013..  386:2287-2323. 2015
  • How much donor financing for health is channelled to global versus country-specific aid functions?.  386:2436-2441. 2015
  • Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition..  386:2145-2191. 2015
  • Radiation exposure in relation to the arterial access site used for diagnostic coronary angiography and percutaneous coronary intervention: a systematic review and meta-analysis..  386:2192-2203. 2015
  • Reduce short-lived climate pollutants for multiple benefits..  386:e28-e31. 2015
  • Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation-Lancet Commission on planetary health..  386:1973-2028. 2015
  • Intracerebral haemorrhage, atrial fibrillation, and anticoagulation - Authors' reply..  386:1737. 2015
  • Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development..  386:569-624. 2015
  • Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013..  386:743-800. 2015
  • Pharmacological and emerging therapies in the treatment of chronic angina..  386:691-701. 2015
  • Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs..  386:303-310. 2015
  • Edoxaban and the need for outcomes-based NOAC dosing.  385:2232-2233. 2015
  • 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial..  385:2485-2491. 2015
  • 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial..  385:2477-2484. 2015
  • Department of Error.  385:2576-2576. 2015
  • Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)..  385:2363-2370. 2015
  • Edoxaban and the need for outcomes-based NOAC dosing..  385:2232-2233. 2015
  • Patchy progress on obesity prevention: emerging examples, entrenched barriers, and new thinking..  385:2400-2409. 2015
  • Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial..  385:2465-2476. 2015
  • Strategic science with policy impact..  385:2445-2446. 2015
  • Tenofovir alafenamide for HIV infection: is less more?.  385:2559-2560. 2015
  • The theory and practice of imaging outcomes research..  385:2334-2335. 2015
  • Aligning incentives to fulfil the promise of personalised medicine..  385:2118-2119. 2015
  • Disparities in worldwide treatment of kidney failure..  385:1926-1928. 2015
  • Dual RAAS blockade for kidney failure: hope for the future..  385:2018-2020. 2015
  • Essential surgery: key messages from Disease Control Priorities, 3rd edition..  385:2209-2219. 2015
  • Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials..  385:1397-1405. 2015
  • Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial..  385:956-965. 2015
  • PHOTON-2: hope for patients with HIV and HCV co-infection?.  385:1052-1054. 2015
  • Time to treatment as a quality metric for acute STEMI care..  385:1056-1057. 2015
  • 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): A randomised controlled trial.  385:2485-2491. 2015
  • 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): A randomised controlled trial.  385:2477-2484. 2015
  • Avoiding 40% of the premature deaths in each country, 2010-30: review of national mortality trends to help quantify the UN sustainable development goal for health..  385:239-252. 2015
  • Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013..  385:117-171. 2015
  • PHOTON-2: Hope for patients with HIV and HCV co-infection?.  385:1052-1054. 2015
  • A new era in medical therapy for retinal degenerative disease?.  384:1482-1484. 2014
  • Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply..  384:1097-1098. 2014
  • Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013..  384:1005-1070. 2014
  • Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013..  384:980-1004. 2014
  • Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial..  384:1187-1195. 2014
  • China's distinctive engagement in global health..  384:793-804. 2014
  • Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes..  383:2008-2017. 2014
  • Childhood cancer, endocrine disorders, and cohort studies..  383:1950-1952. 2014
  • Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis..  383:1059-1066. 2014
  • Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis.  383:1059-1066. 2014
  • Authors' reply.  383:950-951. 2014
  • Childhood cancer, endocrine disorders, and cohort studies.  383:1950-1952. 2014
  • Childhood cancer, endocrine disorders, and cohort studies.  383:1950-1952. 2014
  • Compression stockings to prevent post-thrombotic syndrome: A randomised placebo-controlled trial.  383:880-888. 2014
  • Erratum: Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes (Lancet (2014) 383 (2008-17)).  383:2212. 2014
  • Erratum: On behalf of the SOLSTICE Investigators. Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: A randomised phase 2 trial (The Lancet (2014) 384 (1187-1195)).  384:1186. 2014
  • Lessons from the Liverpool Care Pathway-evidence is key.  383:192-193. 2014
  • Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: A randomised phase 2 trial.  384:1187-1195. 2014
  • Stem-cell transplantation for chronic granulomatous disease.  383:390-392. 2014
  • Global health 2035: a world converging within a generation..  382:1898-1955. 2013
  • Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study..  382:1714-1722. 2013
  • Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart..  382:1507-1513. 2013
  • Treatment of age-related macular degeneration..  382:1230-1232. 2013
  • Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.  382:1714-1722. 2013
  • Erratum: Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: A secondary, prespecifi ed analysis of the TRILOGY\ ACS trial (The Lancet (2013) 382 (605-613).  382:768. 2013
  • Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study..  382:614-623. 2013
  • Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial..  382:605-613. 2013
  • What is the optimum adjunctive reperfusion strategy for primary percutaneous coronary intervention?.  382:633-643. 2013
  • Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention..  382:339-352. 2013
  • Exercise for late-life depression? It depends..  382:4-5. 2013
  • Health reform in Pakistan: a call to action..  381:2291-2297. 2013
  • Non-communicable diseases and injuries in Pakistan: strategic priorities..  381:2281-2290. 2013
  • Not time to RELAX in acute heart failure..  381:1813. 2013
  • A strong correlation between expression of Wntless and of human epidermal growth factor receptor 2 in gastric, ovarian, and breast cancers suggests a novel-signalling pathway involving NFκB and STAT3.  381:S106-S106. 2013
  • Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial (vol 380, pg 1749, 2012).  381:204-204. 2013
  • Autoimmune hepatitis.  382:1433-1444. 2013
  • Early-life prevention of non-communicable diseases..  381:3-4. 2013
  • Erratum: Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fi brillation: A secondary analysis of a randomised controlled trial (The Lancet (2012) 380 (1749-58)).  381:204. 2013
  • Lessons from the Liverpool Care Pathway-evidence is key 2013
  • Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): A randomised placebo-controlled trial.  381:29-39. 2013
  • Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial..  381:29-39. 2013
  • Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010..  380:2197-2223. 2012
  • Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010..  380:2163-2196. 2012
  • Prediabetes and the risk of diabetes..  380:1225-1226. 2012
  • Technologies for global health..  380:507-535. 2012
  • The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials..  380:581-590. 2012
  • Prevalence of chronic kidney disease in China..  380:213-214. 2012
  • Age-related macular degeneration..  379:1728-1738. 2012
  • A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies..  379:823-832. 2012
  • Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial..  379:895-904. 2012
  • Haemopoietic stem-cell transplantation for systemic sclerosis.  379:219-219. 2012
  • Haemopoietic stem-cell transplantation for systemic sclerosis - Authors' reply.  379:219-220. 2012
  • CT scans in childhood and risk of leukaemia and brain tumours.  380:1737-1738. 2012
  • Contracts with patients in clinical practice..  379:7-9. 2012
  • Novel melatonin-based treatments for major depression..  379:216. 2012
  • Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data..  379:322-334. 2012
  • Addressing the vaccine confidence gap..  378:526-535. 2011
  • Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial..  377:1846-1854. 2011
  • Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial..  377:1341-1352. 2011
  • Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial..  377:1409-1420. 2011
  • Pay-for-performance and the Millennium Development Goals..  377:1383-1385. 2011
  • Addressing the vaccine confidence gap.  378:526-535. 2011
  • Antithrombin alternatives in STEMI.  378:643-645. 2011
  • Decompression illness..  377:153-164. 2011
  • Pakistan: the final frontier for a polio-free world.  377:207-208. 2011
  • Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: Collaborative analysis of 58 prospective studies.  377:1085-1095. 2011
  • Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170 000 participants in 26 randomised trials.  376:1670-1681. 2010
  • Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial..  376:1233-1243. 2010
  • Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial..  376:1320-1328. 2010
  • Mixed messages on systemic therapies for diabetic retinopathy..  376:1461. 2010
  • Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial..  376:784-793. 2010
  • Global operating theatre distribution and pulse oximetry supply: an estimation from reported data..  376:1055-1061. 2010
  • Tracking radiation exposure of patients..  376:754-755. 2010
  • Common genetic determinants of vitamin D insufficiency: a genome-wide association study..  376:180-188. 2010
  • Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis..  375:2073-2081. 2010
  • Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies..  375:1634-1639. 2010
  • Environmental health in China: progress towards clean air and safe water..  375:1110-1119. 2010
  • The role of academic health science systems in the transformation of medicine..  375:949-953. 2010
  • Eating disorders..  375:583-593. 2010
  • Liver disease in pregnancy..  375:594-605. 2010
  • Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study..  375:283-293. 2010
  • Ageing and health - Authors' reply.  375:26-27. 2010
  • Ageing and health reply.  375:26-27. 2010
  • C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis..  375:132-140. 2010
  • Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies.  375:2215-2222. 2010
  • Tracking China's health reform.  375:1056-1058. 2010
  • Responding to China's hypertensive crisis..  374:1728-1729. 2009
  • Standardised metrics for global surgical surveillance.  374:1113-1117. 2009
  • Ageing populations: the challenges ahead..  374:1196-1208. 2009
  • James Vaupel: an innovator in the demography of ageing. Interview by Samuel Loewenberg..  374:1139. 2009
  • Second primary cancers in survivors of childhood cancer..  374:1484-1485. 2009
  • Albuminuria in chronic heart failure: prevalence and prognostic importance..  374:543-550. 2009
  • Key issues for global cardiovascular medicine..  374:508-510. 2009
  • Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial..  373:1958-1965. 2009
  • Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial..  373:1949-1957. 2009
  • Towards a common definition of global health..  373:1993-1995. 2009
  • Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials..  373:1190-1197. 2009
  • Public disclosure of clinical research..  373:1319-1320. 2009
  • Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial..  373:1097-1104. 2009
  • Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study..  373:739-745. 2009
  • Community-based newborn care in Bangladesh..  372:1541. 2008
  • Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya..  372:1555-1562. 2008
  • Reform of how health care is paid for in China: challenges and opportunities..  372:1846-1853. 2008
  • Tackling the challenges to health equity in China..  372:1493-1501. 2008
  • DIRECT new treatments for diabetic retinopathy..  372:1361-1363. 2008
  • The history and challenge of HIV prevention..  372:475-488. 2008
  • An estimation of the global volume of surgery: a modelling strategy based on available data..  372:139-144. 2008
  • Cognitive estrangement, science fiction, and medical ethics..  371:1908-1909. 2008
  • Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood..  371:2201-2212. 2008
  • Immunisation against poliomyelitis: moving forward.  371:1385-1387. 2008
  • Fenofibrate and diabetic retinopathy..  371:721-722. 2008
  • Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies..  371:736-743. 2008
  • PCI at non-PCI centres: immediate or rescue?.  371:534-536. 2008
  • Combination HIV prevention.  372:1805-1806. 2008
  • Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial.  371:1839-1847. 2008
  • Waterboarding is not torture: a physician's response.  371:1838-. 2008
  • New treatments for age-related macular degeneration - Authors' reply.  370:1480. 2007
  • Appropriate prescribing in elderly people: how well can it be measured and optimised?.  370:173-184. 2007
  • Clinical update: new treatments for age-related macular degeneration..  370:204-206. 2007
  • Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study..  369:1947-1954. 2007
  • Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial..  369:907-919. 2007
  • Pelvic organ prolapse..  369:1027-1038. 2007
  • Sexual dysfunction in men and women with endocrine disorders..  369:597-611. 2007
  • The eye in hypertension..  369:425-435. 2007
  • Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial..  368:1248-1253. 2006
  • Central nervous system injury associated with cardiac surgery..  368:694-703. 2006
  • Facilitated versus primary PCI for acute myocardial infarction - Authors' reply.  367:1813-1814. 2006
  • Liver cirrhosis mortality rates in Britain..  367:1898-1899. 2006
  • Trial summaries on results databases and journal publication..  367:1635-1636. 2006
  • PLoS Medicine and the pharmaceutical industry.  367:1318. 2006
  • Recent developments and controversies in depression..  367:1235-1236. 2006
  • Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial..  367:29-35. 2006
  • Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial..  366:2005-2011. 2005
  • Are the clinical effects of homoeopathy placebo effects?.  366:2081-2082. 2005
  • Are the clinical effects of homoeopathy placebo effects?.  366:2082-2083. 2005
  • The MANTRA II study – Authors' reply.  366:1770-1771. 2005
  • The MANTRA II study..  366:1769. 2005
  • Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial..  366:643-648. 2005
  • Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study..  366:211-217. 2005
  • The Good Clinical Practice guideline: a bronze standard for clinical research..  366:172-174. 2005
  • Blood vessels engineered from human cells..  365:2122-2124. 2005
  • CT colonography for detection of colon polyps and cancer..  365:1464-1465. 2005
  • Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison..  365:305-311. 2005
  • Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials.  366:2087-2106. 2005
  • Hepatocellular carcinoma [5] (multiple letters).  363:898-899. 2004
  • A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4)..  363:852-859. 2004
  • Viral hepatitis C [7] (multiple letters).  363:661. 2004
  • International differences in evolution of early discharge after acute myocardial infarction..  363:511-517. 2004
  • The CHARM programme - Reply.  362:1678-1679. 2003
  • Depression as risk factor for mortality after coronary artery bypass surgery - Reply.  362:1501-1502. 2003
  • The CHARM programme..  362:1675-1676. 2003
  • Erratum: As this was before furosemide was widely available, I called for nasal oxygen, 2 mL of subcutaneous thiomerin, and a quarter of a grain of morphine (Lancet (April 26, 2003) 361 (1417).  362:836. 2003
  • Anatomical loci of HIV-associated immune activation and association with viraemia..  362:945-950. 2003
  • Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial..  362:777-781. 2003
  • Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial..  362:772-776. 2003
  • Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial..  362:767-771. 2003
  • Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme..  362:759-766. 2003
  • Erratum: Physicians' willingness to participate in the process of lethal injection for capital punishment. Ann Intern Med (Lancet (2001) 135 (884-888)).  362:334. 2003
  • Gene expression predictors of breast cancer outcomes..  361:1590-1596. 2003
  • Telomere shortening in cultured autografts of patients with burns..  361:1345-1346. 2003
  • Two hard lessons..  361:1417. 2003
  • Primary angioplasty or thrombolysis for acute myocardial infarction?.  361:965-966. 2003
  • Primary angioplasty or thrombolysis for acute myocardial infarction?.  361:966-967. 2003
  • Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production..  361:676-678. 2003
  • Increased nitric oxide production and protection from malaria - Reply.  361:610-611. 2003
  • Treatment options for genetically determined immunodeficiency..  361:541-542. 2003
  • Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study..  361:374-379. 2003
  • Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: A meta-analysis.  362:1605-1611. 2003
  • Inhaled ethyl nitrite gas for persistent pulmonary hypertension in infants - Reply.  360:2077-2077. 2002
  • Inhaled ethyl nitrite gas for persistent pulmonary hypertension in infants..  360:2076-2077. 2002
  • A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children..  360:1468-1475. 2002
  • Association between children's experience of socioeconomic disadvantage and adult health: a life-course study..  360:1640-1645. 2002
  • Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy..  360:1662-1664. 2002
  • Gene therapy for SCID--a complication after remarkable progress..  360:1185-1186. 2002
  • Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial..  360:1136-1143. 2002
  • Hypothyroidism in house officers..  360:879. 2002
  • Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum..  360:610-617. 2002
  • Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn..  360:141-143. 2002
  • Absolute and relative truth in clinical trials..  359:1945-1946. 2002
  • Detection of proximal colorectal cancers through analysis of faecal DNA..  359:403-404. 2002
  • Coronary reperfusion: numerators searching for denominators..  359:371-372. 2002
  • Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials..  359:189-198. 2002
  • Sensitivity of a clinical examination to predict need for radiography in children with ankle injuries: a prospective study..  358:2118-2121. 2001
  • Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial..  358:1855-1863. 2001
  • Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study..  358:1119-1123. 2001
  • Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study..  358:1134-1140. 2001
  • Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria..  358:890-891. 2001
  • Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine..  358:1066-1067. 2001
  • Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.  358:545-549. 2001
  • Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction..  358:605-613. 2001
  • Smoking cessation and the course of major depression: a follow-up study..  357:1929-1932. 2001
  • Drug-company sponsorship and the Declaration of Helsinki - Reply.  357:1448-1449. 2001
  • Drug-company sponsorship and the Declaration of Helsinki..  357:1448-1449. 2001
  • Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study..  357:1063-1068. 2001
  • Erratum: Intracranial haemorrhage with bolus thrombolytic agents (The Lancet (November 25) (1849)).  357:642. 2001
  • Towards a genomic-based diagnosis..  357:249-250. 2001
  • Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction..  357:21-28. 2001
  • Chimerism in children with juvenile dermatomyositis..  356:2156-2157. 2000
  • Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial..  356:2037-2044. 2000
  • Grey-matter lesions and dementia..  356:1686-1687. 2000
  • Randomisation in the SYMPHONY trial - Reply.  356:1521-1522. 2000
  • Randomisation in the SYMPHONY trial..  356:1521-1522. 2000
  • Surgery for colorectal cancer in elderly patients: A systematic review.  356:968-974. 2000
  • Cardiogenic shock complicating acute coronary syndromes..  356:749-756. 2000
  • The uncertainty principle and industry-sponsored research..  356:635-638. 2000
  • All that glitters is not gold..  355:1568-1569. 2000
  • Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial. The SYMPHONY Investigators. Sibrafiban versus Aspirin to Yield Maximum Protection from Ischemic Heart Events Post-acute Coronary Syndromes..  355:337-345. 2000
  • Control of meningococcal disease in west Africa (multiple letters).  355:1184-1186. 2000
  • Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa..  355:30-33. 2000
  • Intracranial haemorrhage with bolus thrombolytic agents [1] (multiple letters).  356:1848-1850. 2000
  • Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting..  354:2019-2024. 1999
  • Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group..  354:1932-1939. 1999
  • Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting..  354:2019-2024. 1999
  • Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries..  354:1159-1163. 1999
  • Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial..  354:1493-1498. 1999
  • Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial..  354:716-722. 1999
  • Jhum-jhum: neuropsychiatric symptoms in a Nepali village..  353:1070. 1999
  • Cholinergic therapy for Down's syndrome..  353:1064-1065. 1999
  • Kidney cancer..  353:594. 1999
  • Prediction of cognitive decline in early Alzheimer's disease..  352:1678. 1998
  • A tooth per child?.  352:204. 1998
  • Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade..  352:87-92. 1998
  • Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure..  351:1317-1319. 1998
  • Prenatal exposure to famine and health in later life..  351:1361. 1998
  • Molecular assays for surveillance of antifolate-resistant malaria..  351:1629-1630. 1998
  • Prenatal exposure to famine and health in later life..  351:1360-1361. 1998
  • Magnesium in in-hospital cardiac arrest..  351:445-446. 1998
  • A tooth per child? (multiple letters) [2].  352:1386-1387. 1998
  • Epidermal growth factor in saliva and serum of infants with necrotising enterocolitis..  351:266-267. 1998
  • Tamoxifen for early breast cancer: An overview of the randomised trials.  351:1451-1467. 1998
  • Gastroenterology. Lasers come of age..  350 Suppl 3:SIII7. 1997
  • Future vaccines and a global perspective..  350:1767-1770. 1997
  • From antiphospholipid syndrome to antibody-mediated thrombosis..  350:1491-1493. 1997
  • Randomised, controlled, community-level HIV-prevention intervention for sexual-risk behaviour among homosexual men in US cities.  350:1500-1505. 1997
  • Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff..  350:1272-1276. 1997
  • Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff..  350:1272-1276. 1997
  • Randomised, controlled, community-level HIV-prevention intervention for sexual-risk behaviour among homosexual men in US cities. Community HIV Prevention Research Collaborative..  350:1500-1505. 1997
  • Osler and Ernulf's curse..  350:1245-1246. 1997
  • Effect on infant mortality of iodination of irrigation water in a severely iodine-deficient area of China..  350:771-773. 1997
  • Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II..  349:1422-1428. 1997
  • Early management of acute severe asthma..  349:1030. 1997
  • Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor..  349:775-776. 1997
  • Immunotherapy for HIV - Reply.  349:434-434. 1997
  • Rapid self testing for HIV infection..  349:352-353. 1997
  • Department of error: (New frontiers of immunotherapy for HIV, December 7 (1531)).  349:510. 1997
  • Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial..  349:75-78. 1997
  • Lasers come of age.  350. 1997
  • New frontiers of immunotherapy for HIV..  348:1531-1532. 1996
  • HIV vaccines: where we are and where we are going..  348:933-937. 1996
  • Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease..  348:90-93. 1996
  • Returning home: reflections on the USA's response to the HIV/AIDS epidemic..  347:1673-1676. 1996
  • Presenilin-1 polymorphism and Alzheimer's disease..  347:1560. 1996
  • Presenilin-1 polymorphism and Alzheimer's disease..  347:1186-1187. 1996
  • Alzheimer's disease in twins..  347:976. 1996
  • c-ANCA as a marker of Wegener's disease - Reply.  347:118-118. 1996
  • Alzheimer's disease in twins [20].  347:975-976. 1996
  • Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan.  348:83-85. 1996
  • A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis..  346:926-931. 1995
  • ApoE genotype and survival from intracerebral haemorrhage..  346:575. 1995
  • Hepatic focal nodular hyperplasia in infant antenatally exposed to steroids..  346:371. 1995
  • Identical-twin small-bowel transplant for desmoid tumour..  345:1577-1578. 1995
  • Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease..  345:1600-1603. 1995
  • ISIS-4..  345:1372-1373. 1995
  • External examiners..  345:1093-1095. 1995
  • Neuroleptic treatment and caudate plasticity..  345:734-735. 1995
  • Sex of editor in medical journals..  345:662. 1995
  • Smoking, Alzheimer's disease, and confounding with genes..  345:387. 1995
  • Apolipoprotein E in Creutzfeldt-Jacob disease..  345:69. 1995
  • Dentatorubral-pallidoluysian atrophy and Haw River syndrome..  344:1711-1712. 1994
  • Obstetric damage and faecal incontinence..  344:1435. 1994
  • Effect of coronary artery bypass graft surgery on survival..  344:1223. 1994
  • On being poor with HIV..  344:1100-1101. 1994
  • Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura..  344:703-707. 1994
  • Are SSRI antidepressants clinically homogeneous?.  344:550. 1994
  • Role of selectins in development of adult respiratory distress syndrome..  344:215-219. 1994
  • Iodination of irrigation water as a method of supplying iodine to a severely iodine-deficient population in Xinjiang, China..  344:107-110. 1994
  • Clinical application of apolipoprotein E genotyping to Alzheimer's disease..  343:1564-1565. 1994
  • Magnesium and myocardial infarction..  343:1285. 1994
  • Reduced GABA synthesis in pyridoxine-dependent seizures..  343:1133-1134. 1994
  • Sumatriptan-induced stroke in sagittal sinus thrombosis..  343:1105-1106. 1994
  • Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators..  343:881-886. 1994
  • Do non-scientists really live longer?.  343:296. 1994
  • Individual risk assessment for intracranial haemorrhage during thrombolytic therapy.  342:1523-1528. 1993
  • Chronic fetal vascular access..  342:1086-1087. 1993
  • Fertilising ability of testicular spermatozoa..  342:864. 1993
  • Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases..  342:710-711. 1993
  • World Bank's world development report..  342:440. 1993
  • Once-daily aminoglycoside dosing..  341:895. 1993
  • Once-daily aminoglycoside dosing..  341:894-895. 1993
  • Idiopathic CD4+ T-lymphocytopenia..  340:608-609. 1992
  • Idiopathic CD4+ T-lymphocytopenia..  340:607-608. 1992
  • G-CSF and peripheral blood progenitor cells..  339:1410. 1992
  • Cyclosporin and asthma..  339:873. 1992
  • DNA adducts and exposure to burning oil..  339:489. 1992
  • HIV-1 sensitivity to zidovudine and clinical outcome in children..  339:15-19. 1992
  • Phylogeny of the Whipple's-disease-associated bacterium..  338:474-475. 1991
  • Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study..  338:265-269. 1991
  • Medical education in the community: a Nigerian experience..  338:99-102. 1991
  • The acromegalic rosary.  337:860-861. 1991
  • Aerosol alpha 1-antitrypsin treatment for cystic fibrosis..  337:392-394. 1991
  • Hypothesis: is lung disease after silicate inhalation caused by oxidant generation?.  336:967-969. 1990
  • Mutations in medium chain acyl-CoA dehydrogenase deficiency (II).  336:748-749. 1990
  • Increase in admissions for Neisseria meningitidis infection in Australia..  2:1464. 1989
  • Bacteriotherapy for clostridium difficile colitis..  2:1096. 1989
  • HYPERBARIC OXYGEN FOR CARBON MONOXIDE POISONING.  334:1032-1033. 1989
  • Direct carrier testing in 14 families with haemophilia B..  2:526-529. 1989
  • Zidovudine-induced neutropenia: are we too cautious?.  2:91-92. 1989
  • Patent foramen ovale and decompression sickness in divers..  1:513-514. 1989
  • Patient foramen ovale and decompression sickness in divers.  1:513-514. 1989
  • Importance of electrocardiography for coronary risk factor surveys..  2:633-634. 1988
  • Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals..  1:902-905. 1988
  • Antibody-dependent enhancement of human immunodeficiency virus type 1 infection..  1:790-794. 1988
  • Recombinant human granulocyte-macrophage colony-stimulating factor produces fever..  1:950. 1988
  • Tamoxifen versus surgery in elderly patients with breast cancer..  1:891-892. 1988
  • Adolescent colorectal cancer and dioxin exposure..  2:803. 1987
  • Clinical, immunological, and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS or AIDS-related complex..  1:1286-1292. 1987
  • Mismatched double-stranded RNA (ampligen) reduces concentration of zidovudine (azidothymidine) required for in-vitro inhibition of human immunodeficiency virus..  1:890-892. 1987
  • Post-mortem recognition of inherited metabolic disorders from specific acylcarnitines in tissue in cases of sudden infant death..  1:512. 1987
  • Confidentiality and pre-employment health screening..  1:104. 1987
  • Sleep disruption, calorie restriction, and biological markers for depression..  2:1390. 1986
  • Food incentives to improve clinic attendance..  2:230. 1986
  • Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959..  1:1279-1280. 1986
  • HTLV-III seroconversion associated with heat-treated factor VIII concentrate..  1:611-612. 1986
  • Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex..  1:575-580. 1986
  • Playing the odds..  1:329-330. 1985
  • Association between cyclosporin neurotoxicity and hypomagnesaemia..  2:1116-1120. 1984
  • Antigenic comparison of virus strains of mild and classical types of epidemic haemorrhagic fever isolated in China and adaptation of these to cultures of normal cells..  1:677-678. 1984
  • Antigenic comparison of virus strains of mild and classical types of epidemic haemorrhagic fever isolated in China and adaptation of these to cultures of normal cells..  1:677-678. 1984
  • Benefits and risks of multiple transfer with in vitro fertilisation..  1:570. 1984
  • THE INTERICTAL EEG IN DIAGNOSIS OF EPILEPSY.  2:518-519. 1984
  • Hepatitis B surface antigen could harbour the infective agent of AIDS..  2:882-884. 1983
  • Matchbox sign..  2:457-458. 1983
  • Viruses of classical and mild forms of haemorrhagic fever with renal syndrome isolated in China have similar bunyavirus-like morphology..  1:589-591. 1983
  • Viruses of classical and mild forms of haemorrhagic fever with renal syndrome isolated in China have similar bunyavirus-like morphology..  1:589-591. 1983
  • Oral typhoid vaccine Ty21a..  1:523. 1983
  • Randomised trial of plasma exchange in mild systemic lupus erythematosus..  1:17-22. 1983
  • Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patients..  2:354-357. 1982
  • Cryptococcosis and the basidiospore..  1:1301. 1982
  • Increased brain-type creatine phosphokinase in marathon runners..  1:1310. 1982
  • Cytomegalovirus retinitis and immunodeficiency in homosexual males..  1:958. 1982
  • Detection bias in endometrial cancer..  1:164. 1982
  • Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis..  1:131-132. 1982
  • Marrow transplantation for thalassaemia.  2:227-229. 1982
  • Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation.  2:621-623. 1982
  • Central nervous system leukaemia..  2:633. 1981
  • Kaposi's sarcoma in homosexual men-a report of eight cases..  2:598-600. 1981
  • Necropsy diagnosis of endometrial cancer and detection-bias in case/control studies..  2:66-68. 1981
  • Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine..  1:804-807. 1981
  • Incidence and severity of rotavirus and Escherichia coli diarrhoea in rural Bangladesh. Implications for vaccine development..  1:141-143. 1981
  • CENTRAL NERVOUS SYSTEM LEUKAEMIA.  318:633-. 1981
  • Dexamethasone suppression test in depression..  2:1249. 1980
  • Safety and patient acceptability of intravenous immune globulin in 10% maltose..  2:1158-1159. 1980
  • Carpal tunnel syndrome in porphyria..  2:808. 1980
  • IgA in saliva of breast-fed and bottle-fed infants..  2:543. 1980
  • Use of antisera for identification of enterotoxigenic Escherichia coli..  2:222-224. 1980
  • Valproate, hyperammonemia, and hyperglycinemia..  2:260-261. 1980
  • Maternal cholera immunisation and scecretory IgA in breast milk..  1:931-932. 1980
  • Schizophrenia and cancer death..  1:480-481. 1980
  • Neuroendocrine disturbances and the diagnosis and aetiology of endogenous depression..  1:321-322. 1980
  • IgA IN SALIVA OF BREAST-FED AND BOTTLE-FED INFANTS.  316:543. 1980
  • Ultrasound detection of brain damage in preterm infants..  1:1261-1264. 1979
  • Progression of diabetic nephropathy..  1:1105-1106. 1979
  • Peptic ulcer after renal transplantation..  1:562. 1979
  • Misdiagnoses of endogenous depression with research diagnostic criteria..  1:267. 1979
  • "Insulin" allergy due to zinc..  1:122-124. 1979
  • Renal transplantation in insulin-requiring diabetics..  1:153. 1979
  • Oral hydration rotavirus diarrhoea: a double blind comparison of sucrose with glucose electrolyte solution..  2:280-283. 1978
  • Cimetidine and renal-allograft rejection..  1:1154. 1978
  • Legionnaires' disease..  2:1083. 1977
  • Heparin-induced decrease in circulating antithrombin-III..  2:581-584. 1977
  • Identification of Duchenne muscular dystrophy carriers..  2:636. 1976
  • Letter: Cholinergic side-effects associated with deanol..  2:50-51. 1976
  • Role of gluten, prednisone, and azathioprine in non-responsive coeliac disease..  1:1213-1216. 1976
  • Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh..  1:659-663. 1976
  • Depressed monocyte chemotaxis during acute influenza infection..  2:1063-1066. 1975
  • A continuing common-source outbreak of botulism in a family..  2:861-863. 1975
  • Diarrhoea associated with heat-stable enterotoxin-producing strains of Escherichia coli..  2:239-241. 1975
  • ENHANCED BACTERICIDAL ACTIVITY OF PHAGOCYTES FROM PATIENTS WITH CHRONIC GRANULOMATOUS DISEASE IN THE PRESENCE OF SULPHISOXAZOLE.  305:824-827. 1975
  • Enhanced bactericidal activity of phagocytes from patients with chronic granulomatous disease in the presence of sulphisoxazole..  1:824-827. 1975
  • Bird-mite infestation in a university hospital..  1:445. 1975
  • Outbreak of psychosomatic illness at a rural elementary school..  2:1500-1503. 1974
  • Letter: Incidence of childhood leukaemia..  2:862. 1973
  • Continuous prostaglandin-F 2 infusion for middle-trimester abortion..  1:1195. 1973
  • Urinary cyclic adenosine monophosphate as an aid in the diagnosis of hyperparathyroidism..  1:631-633. 1973
  • Cholinergic reversal of manic symptoms..  1:427-428. 1973
  • EPSTEIN-BARR VIRUS AND GUILLAIN-BARRÉ SYNDROME.  301:151. 1973
  • Epstein-Barr virus and Guillain-Barrè syndrome..  1:151. 1973
  • Granulomatous hepatitis associated with acute cytomegalovirus infection..  1:20-22. 1973
  • GRANULOMATOUS HEPATITIS ASSOCIATED WITH ACUTE CYTOMEGALOVIRUS INFECTION.  301:20-22. 1973
  • L-tryptophan as an antidepressant..  1:915. 1971
  • What causes whooping-cough?.  2:1079. 1970
  • L-tryptophan in depression..  2:776. 1970
  • Epidemic shiga dysentery in Central America..  2:661-662. 1970
  • L-tryptophan in depression..  1:1228. 1970
  • Sequential comparison of L-tryptophan with E.C.T. in severe depression..  1:967-969. 1970
  • Role of the microvillus in the absorption of disaccharides..  2:154-157. 1968
  • Pituitary-adrenal function in depression..  1:1373-1374. 1968
  • Collagenolytic activity of the skin associated with neuromuscular diseases including amyotrophic lateral sclerosis..  1:1007-1009. 1966
  • DISACCHARIDE INTOLERANCE AND MUCOVISCIDOSIS..  2:120-121. 1964
  • CHILDHOOD DEPRESSION.  323:1409.
  • MERALGIA PARÆSTHETICA AND EPSTEIN-BARR VIRUS.  309:914.
  • Concepts of blood transfusion in adults..  381:1845-1854. 2013
  • Antifibrinolytic therapy: New data and new concepts.  376:3-4. 2010
  • Kidney transplantation with rabbit antithymocyte globulin and sirolimus monotherapy..  361:969. 2003
  • Inherited deletion at Duchenne dystrophy locus in normal male..  1:496-497. 1989
  • Will antibody-dependent enhancement of HIV-1 infection be a problem with AIDS vaccines?.  1:830-831. 1988
  • Inherited deletion at Duchenne dystrophy locus in normal male..  2:1154-1155. 1987
  • Speech therapy for aphasic stroke patients..  1:1413-1414. 1984
  • Can Jiangsu province achieve the health-related Sustainable Development Goals and Healthy Jiangsu 2030 goals? A systematic analysis on the current situation and projected attainment 2018
  • Residential greenness and mortality in oldest-old women and men in China: a prospective cohort study 2018
  • Effect of coastal marine protection on childhood health: an exploratory study 2017
  • Linear child growth after a natural disaster: a longitudinal study of the effects of the 2004 Indian Ocean tsunami 2017
  • Analysis of the equity of emergency medical services: a cross-sectional survey in Chongqing city 2015
  • Task shifting of traditional birth attendants in rural China: a qualitative study of the implementation of institution-based delivery policy 2015
  • The first inborn error of manganese metabolism caused by mutations in SLC30A10, a newly identified manganese transporter 2013
  • Diabetic retinopathy. 2010
  • Pancreatic cancer. 2004